Back to Search
Start Over
Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes With Central Serous Chorioretinopathy.
- Source :
-
American journal of ophthalmology [Am J Ophthalmol] 2023 Dec; Vol. 256, pp. 164-174. Date of Electronic Publication: 2023 Jun 17. - Publication Year :
- 2023
-
Abstract
- Purpose: This study aimed to examine baseline characteristics for identifying factors associated with vision loss (VL) in patients with central serous chorioretinopathy (CSC) who successfully responded to photodynamic therapy (PDT).<br />Design: A retrospective, clinical case-control study.<br />Methods: This study included 85 eyes with CSC, which underwent PDT, and resolved serous retinal detachment. These eyes were classified into 2 groups: the VL group (best-corrected visual acuity 6 months after PDT was worse than that at baseline) and the vision maintenance or improved group (the others). Baseline factors were analyzed to determine the characteristics of the VL group and assess the diagnostic potential of these factors.<br />Result: Seventeen eyes were included in the VL group. The mean values of the neurosensory retinal (NSR) thickness, the internal limiting membrane-external limiting membrane thickness (IET), and the external limiting membrane-photoreceptor outer segment thickness (EOT) in the VL group were significantly thinner than those in the vision maintenance or improved group (NSR thickness, 123.2 ± 39.7 µm vs 166.3 ± 49.6 µm, P < .001; IET, 63.1 ± 17.0 µm vs 88.0 ± 25.4 µm, P < .001; EOT, 60.1 ± 28.6 µm vs 78.3 ± 33.1, P = .041). The sensitivity, specificity, and positive and negative predictive values for predicting VL were 94.1%, 50.0%, 32.0%, and 97.1% for NSR thickness; 94.1%, 51.5%, 32.7%, and 97.2% for IET; and 94.1%, 30.9%, 25.4%, and 95.5% for EOT, respectively.<br />Conclusions: Pretreatment sensory retinal layer thickness could predict VL after PDT for CSC and may be a helpful reference for PDT.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Verteporfin therapeutic use
Retrospective Studies
Case-Control Studies
Tomography, Optical Coherence
Visual Acuity
Photosensitizing Agents therapeutic use
Fluorescein Angiography
Chronic Disease
Central Serous Chorioretinopathy diagnosis
Central Serous Chorioretinopathy drug therapy
Photochemotherapy
Porphyrins therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1891
- Volume :
- 256
- Database :
- MEDLINE
- Journal :
- American journal of ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 37331678
- Full Text :
- https://doi.org/10.1016/j.ajo.2023.05.022